We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.1B
AUM Growth
+$5.57B
(+17%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
262
Reduced
309
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$2.28B |
| 2 |
Otis Worldwide
OTIS
|
+$193M |
| 3 |
Burlington
BURL
|
+$191M |
| 4 |
AbbVie
ABBV
|
+$178M |
| 5 |
Wayfair
W
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Lockheed Martin
LMT
|
+$339M |
| 3 |
Johnson & Johnson
JNJ
|
+$262M |
| 4 |
Pfizer
PFE
|
+$167M |
| 5 |
Target
TGT
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Financials | 11.33% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Ally Financial
ALLY
$13.2B
| $144M | 0.37% |
7,256,722
+1,832,045
| +34% | +$31.2M |
|
52
Nike
NKE
$61.9B
| $140M | 0.36% |
1,425,343
+14,205
| +1% | +$1.31M |
|
53
Ross Stores
ROST
$80.5B
| $138M | 0.35% |
1,623,539
+58,100
| +4% | +$5.26M |
|
54
T-Mobile US
TMUS
$185B
| $138M | 0.35% |
1,325,834
+785,717
| +145% | +$75.3M |
|
55
Medtronic
MDT
$109B
| $138M | 0.35% |
1,500,720
-295,571
| -16% | -$28.3M |
|
56
Texas Instruments
TXN
$252B
| $134M | 0.34% |
1,058,544
+235,700
| +29% | +$27.5M |
|
57
United Therapeutics
UTHR
$25.8B
| $133M | 0.34% |
1,100,000
-186,622
| -15% | -$21M |
|
58
Union Pacific
UNP
$174B
| $132M | 0.34% |
782,214
+86,000
| +12% | +$13.8M |
|
59
CenterPoint Energy
CNP
$27.7B
| $132M | 0.34% |
7,058,239
+3,787,000
| +116% | +$65.2M |
|
60
American Tower
AMT
$80.8B
| $132M | 0.34% |
508,744
+700
| +0.1% | +$173K |
|
61
Under Armour Class C
UA
$2.77B
| $130M | 0.33% |
14,733,891
+4,145,600
| +39% | +$35.2M |
|
62
Linde
LIN
$221B
| $129M | 0.33% |
609,035
-9,900
| -2% | -$1.91M |
|
63
Danaher
DHR
$137B
| $129M | 0.33% |
822,091
+108,378
| +15% | +$15.6M |
|
64
The Mosaic Company
MOS
$7.03B
| $127M | 0.33% |
10,191,305
-1,207,100
| -11% | -$14.5M |
|
65
Philip Morris
PM
$297B
| $126M | 0.32% |
1,797,354
+13,000
| +0.7% | +$948K |
|
66
Bunge Global
BG
$20.4B
| $125M | 0.32% |
3,044,310
+550,000
| +22% | +$21.3M |
|
67
NextEra Energy
NEE
$181B
| $123M | 0.31% |
2,045,384
-848,800
| -29% | -$50.8M |
|
|
B
68
Barrick Mining
B
$61.5B
| $121M | 0.31% |
4,500,000
-2,000,000
| -31% | -$50M |
|
69
Timken Company
TKR
$9.56B
| $121M | 0.31% |
2,652,579
+77,463
| +3% | +$3.06M |
|
70
Broadcom
AVGO
$1.85T
| $119M | 0.3% |
3,755,260
-579,000
| -13% | -$16.2M |
|
71
Five Below
FIVE
$12B
| $117M | 0.3% |
+1,090,000
| New | +$102M |
|
72
Vertex Pharmaceuticals
VRTX
$121B
| $116M | 0.3% |
399,652
-511,300
| -56% | -$139M |
|
73
TJX Companies
TJX
$174B
| $116M | 0.3% |
2,290,664
-1,059,000
| -32% | -$53.2M |
|
74
Edison International
EIX
$28.2B
| $115M | 0.29% |
2,114,484
+441,200
| +26% | +$25.4M |
|
75
Lam Research
LRCX
$367B
| $113M | 0.29% |
3,489,040
-334,000
| -9% | -$9.11M |
|
Similar funds
Adage Capital Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Adage Capital Partners held 834 positions worth $39.1B, up 17% from $33.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q2 2020, closing 110 positions and reducing 309 holdings. Its most notable exit was Allergan plc, an estimated $1.66B position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Royalty Pharma worth $2.23B.
- Adage Capital Partners's largest Q2 2020 buy was Royalty Pharma: 46,015,330 shares worth $2.23B.
- Adage Capital Partners added most to Burlington in Q2 2020, an estimated $191M increase.
- Adage Capital Partners's biggest Q2 2020 reduction was Lockheed Martin, cutting an estimated $339M.
- Adage Capital Partners fully exited Allergan plc in Q2 2020, selling an estimated $1.66B.
- Adage Capital Partners's ten largest holdings make up 25% of its $39.1B portfolio in Q2 2020.
- Adage Capital Partners opened 111 new positions and closed 110 in Q2 2020.
- Adage Capital Partners's portfolio value rose 17% quarter-over-quarter to $39.1B.
Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.